Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,459,000 | 13,393,000 | 7,517,000 | 12,407,000 | 9,658,000 |
| Marketable Securities | 1,998,000 | 1,035,000 | 11,413,000 | 15,922,000 | 1,905,000 |
| Receivables | 7,556,000 | 7,533,000 | 8,334,000 | 8,283,000 | 8,456,000 |
| Inventories | 5,723,000 | 5,913,000 | 7,175,000 | 6,666,000 | 7,131,000 |
| Other current assets | 2,968,000 | 2,607,000 | 2,471,000 | 2,440,000 | 2,523,000 |
| TOTAL | $29,704,000 | $30,481,000 | $36,910,000 | $45,718,000 | $29,673,000 |
| Non-Current Assets | |||||
| PPE Net | 9,458,000 | 9,514,000 | 10,764,000 | 11,545,000 | 12,263,000 |
| Investments And Advances | 2,134,000 | 2,812,000 | 2,554,000 | 3,241,000 | 12,533,000 |
| Intangibles | 51,671,000 | 50,220,000 | 60,945,000 | 63,777,000 | 66,808,000 |
| Other Non-Current Assets | 9,279,000 | 6,918,000 | 6,280,000 | 7,514,000 | 6,501,000 |
| TOTAL | $72,542,000 | $69,464,000 | $80,543,000 | $86,077,000 | $98,105,000 |
| Total Assets | $102,246,000 | $99,945,000 | $117,453,000 | $131,795,000 | $127,778,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,232,000 | 6,175,000 | 5,931,000 | 6,295,000 | 9,785,000 |
| Accounts payable and accrued liabilities | 4,572,000 | 4,926,000 | 5,146,000 | 5,553,000 | 5,403,000 |
| Other current liabilities | 14,054,000 | 13,166,000 | 14,795,000 | 15,670,000 | 15,127,000 |
| TOTAL | $28,692,000 | $26,390,000 | $28,656,000 | $30,208,000 | $33,059,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 21,366,000 | 18,436,000 | 20,244,000 | 22,902,000 | 26,259,000 |
| Other Non-Current Liabilities | 5,645,000 | 6,117,000 | 6,444,000 | 7,796,000 | 8,654,000 |
| TOTAL | $29,428,000 | $26,805,000 | $29,374,000 | $33,765,000 | $38,053,000 |
| Total Liabilities | $58,120,000 | $53,195,000 | $58,030,000 | $63,973,000 | $71,112,000 |
| Shareholders' Equity | |||||
| Common Shares | 793,000 | 825,000 | 890,000 | 901,000 | 913,000 |
| Retained earnings | 43,306,000 | 45,883,000 | 58,544,000 | 66,802,000 | 55,738,000 |
| Other shareholders' equity | 80,000 | 83,000 | 81,000 | 167,000 | 68,000 |
| TOTAL | $44,126,000 | $46,750,000 | $59,423,000 | $67,822,000 | $56,666,000 |
| Total Liabilities And Equity | $102,246,000 | $99,945,000 | $117,453,000 | $131,795,000 | $127,778,000 |